Author:
Haynes Richard,Valdes-Marquez Elsa,Hopewell Jemma C.,Chen Fang,Li Jing,Parish Sarah,Landray Martin J.,Armitage Jane,Haynes Richard,Valdes-Marquez Elsa,Hopewell Jemma C.,Chen Fang,Li Jing,Parish Sarah,Landray Martin J.,Armitage Jane,Collins R.,Armitage J.,Baigent C.,Chen Z.,Landray M.J.,Chen Y.,Jiang L.,Pedersen T.,Landray M.J.,Bowman L.,Haynes R.,Rahimi K.,Tobert J.,Sleight P.,Simpson D.,Parish S.,Baxter A.,Lay M.,Bray C.,Wincott E.,van Leijenhorst G.,Mitchel Y.,Kuznetsova O.
Funder
Merck & Co Inc
UK Medical Research Council
British Heart Foundation and Cancer Research UK
British Heart Foundation
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines;Grundy;J Am Coll Cardiol,2018
2. 2016 ESC/EAS guidelines for the management of dyslipidaemias;Catapano;Eur Heart J,2016
3. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and the european atherosclerosis society (EAS);Catapano;Atherosclerosis,2011
4. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy;The AIM-HIGH Investigators;N Engl J Med,2011
5. Effects of extended-release niacin with laropiprant in high-risk patients;N Engl J Medi,2014